Search Results - "Melson, John W."

Systemic therapy landscape of advanced prostate cancer by Paul, Asit K, Melson, John W, Hirani, Samina, Muthusamy, Selvaraj

“…Prostate cancer is the most commonly diagnosed cancer in American men and 2nd leading cause of cancer-related deaths in the United States. Androgen deprivation…”
Get full text

Screening, Diagnosis, and Initial Care of Asian and White Patients With Lung Cancer by Hu, Xiao, Melson, John W, Pan, Stacey S, Salei, Yana V, Cao, Yu

“…Data on the care of Asian patients with lung cancer in the US are limited; however, lung cancer is the leading cause of cancer death in this population…”
Get full text

Enfortumab vedotin‐induced cutaneous eruption: Ring mitotic figures as a distinctive histopathologic feature by Sport, Catherine, Clawson, Rebecca C., Tisdale, Lauren E., Melson, John W., Mochel, Mark C.

“…Enfortumab vedotin (EV), a nectin‐4‐binding agent that affects microtubules, has become standard therapy for advanced urothelial carcinoma. The agent, now…”
Get full text

Atherosclerotic Cardiovascular Disease Risk and Longitudinal Risk Factor Management Among Patients With Breast Cancer by Melson, John W., Koethe, Benjamin, Mohanty, Sharanya, Babroudi, Seda, Bao, Chen, Chunduru, Amar, Dwaah, Henry, Finn, Matthew, Jain, Annika, Lalla, Mumtu, Patnaik, Paras, Studley, Rachael, Buchsbaum, Rachel J., Huber, Kathryn, Parsons, Susan K., Upshaw, Jenica N.

“…Cardiovascular disease is the leading cause of noncancer mortality for breast cancer survivors. Data are limited regarding patient-level atherosclerotic…”
Get full text

Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report by Shantzer, Lindsey B., Dougherty, Sean C., Bolte, Fabian, Melson, John W., Reed, Daniel R., Lynch, Alia C., Gentzler, Ryan D., Novicoff, Wendy, Hall, Richard D.

“…•The occurrence of an immune related adverse event is prognostically useful in patients receiving immune checkpoint inhibitors in combination with…”
Get full text

Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction by Tetruashvily, Mazell M., Melson, John W., Park, Joseph J., Peng, Xiaoyu, Boulanger, Lisa M.

“…The major histocompatibility complex class I (MHCI) is a large gene family, with over 20 members in mouse. Some MHCIs are well-known for their critical roles…”
Get full text

Presenting symptoms, screening and diagnosis in asian and white patients with stage IV lung cancer by Hu, Xiao, Melson, John W., Pan, Stacey, Salei, Yana, Cao, Yu

“…e18687 Background: Lung cancer (LC) is a leading cancer diagnosis and cause of cancer death in Asian Americans, the fastest growing racial/ethnic group in the…”
Get full text

Statin use for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in breast cancer (BC) patients (pts) by Melson, John W., Koethe, Benjamin, Mohanty, Sharanya, Babroudi, Seda, Bao, Chen, Chunduru, Amar, Dwaah, Henry, Finn, Matthew, Jain, Annika, Lalla, Mumtu, Patnaik, Paras, Studley, Rachael, Buchsbaum, Rachel J., Huber, Kathryn, Parsons, Susan K., Upshaw, Jenica N

“…e24051 Background: CVD is the leading cause of non-cancer mortality for BC survivors. Clinical practice guidelines support the assessment and management of…”
Get full text

Abstract 5528: Palliative and end of life care utilization in Asian and White patients with stage IV lung cancer by Hu, Xiao, Melson, John W., Pan, Stacey, Salei, Yana, Cao, Yu

“…Background: Lung cancer (LC) is the leading cause of cancer death in Asian Americans, the fastest growing racial/ethnic group in the US. Early palliative care…”
Get full text